Enzo Biochem is a diagnostics & research business based in the US. Enzo Biochem shares (ENZ) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $1.04 – a decrease of 9.57% over the previous week. Enzo Biochem employs 125 staff and has a trailing 12-month revenue of around $31.9 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.04 |
|---|---|
| 52-week range | $0.89 - $1.36 |
| 50-day moving average | $1.13 |
| 200-day moving average | $1.16 |
| Wall St. target price | $5.50 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.19 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.14 from 2024-11-14
| 1 week (2024-11-08) | -0.87% |
|---|---|
| 1 month (2024-10-15) | 0.88% |
| 3 months (2024-08-15) | 2.70% |
| 6 months (2024-05-15) | 3.64% |
| 1 year (2023-11-15) | -6.56% |
|---|---|
| 2 years (2022-11-15) | -43.44% |
| 3 years (2021-11-15) | 3.055 |
| 5 years (2019-11-15) | 2.6212 |
| Revenue TTM | $31.9 million |
|---|---|
| Gross profit TTM | $11.6 million |
| Return on assets TTM | -7.44% |
| Return on equity TTM | -14.59% |
| Profit margin | -81.73% |
| Book value | $1.07 |
| Market Capitalization | $59.6 million |
TTM: trailing 12 months
We're not expecting Enzo Biochem to pay a dividend over the next 12 months.
Enzo Biochem's shares were split on a 105:100 basis on 20 October 2004 . So if you had owned 100 shares the day before before the split, the next day you'd have owned 105 shares. This wouldn't directly have changed the overall worth of your Enzo Biochem shares – just the quantity. However, indirectly, the new 4.8% lower share price could have impacted the market appetite for Enzo Biochem shares which in turn could have impacted Enzo Biochem's share price.
Over the last 12 months, Enzo Biochem's shares have ranged in value from as little as $0.8949 up to $1.3558. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Enzo Biochem's is 0.729. This would suggest that Enzo Biochem's shares are less volatile than average (for this exchange).
Enzo Biochem, Inc. , a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.